Literature DB >> 8320515

Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis.

A Stjernquist-Desatnik1, P Samuelsson, M Walder.   

Abstract

In the treatment of group A streptococcal tonsillitis, as the bacteria are located on the epithelial surface, an important determinant of outcome is the concentration of penicillin in extracellular tonsillar surface fluid. Accordingly, we investigated the concentration of penicillin in serum, and penetration to tonsillar surface fluid and saliva in nine patients with acute group A streptococcal tonsillitis and in nine healthy controls. Among the healthy subjects, despite high serum penicillin concentrations (mean, 2.04 micrograms/ml), there was no penetration to tonsillar surface fluid or to saliva, whereas erythromycin penetrated to tonsillar surface fluid in 3/6 cases. Of the nine patients with acute tonsillitis, on the first day of treatment eight manifested high concentrations of penicillin in tonsillar surface fluid (mean, 0.34 micrograms/ml--i.e. well above the minimal inhibitory concentration (MIC) for group A streptococci), but penetration to saliva was found in only two patients. On the tenth day of treatment, penicillin was not present in the saliva of any of the patients and was present in the tonsillar surface fluid of only one. The results suggest that measurable concentrations of penicillin in tonsillar surface fluid can only be obtained in the presence of inflammation with fluid exudation through the tonsillar epithelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320515     DOI: 10.1017/s0022215100122893

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

Review 1.  Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review.

Authors:  Holger Munck; Anders W Jørgensen; Tejs Ehlers Klug
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-13       Impact factor: 3.267

2.  Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

3.  Randomized evaluation of benzathine penicillin V twice daily versus potassium penicillin V three times daily in the treatment of group A streptococcal pharyngitis. Pharyngitis Study Group.

Authors:  A Kaufhold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 4.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

Review 5.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 6.  Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.

Authors:  Itzhak Brook
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-03

Review 7.  Pharyngotonsillitis.

Authors:  Anna Stjernquist-Desatnik; Arne Orrling
Journal:  Periodontol 2000       Date:  2009-02       Impact factor: 7.589

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.